Collaborative study identifies potential targets to treat the most common childhood liver cancer
A collaborative study, led by Cima Universidad de Navarra, has identified key epigenetic targets for its treatment. This research opens ...
Oct 25, 2023
FDA Expands Rozlytrek Indication to Include Some Solid Tumors in Children at Least 1 Month Old
The Food and Drug Administration (FDA) approved an expanded indication for Rozlytrek (entrectinib) to include children older than one...
Oct 23, 2023
Second Dose of Palonosetron Reduces CINV in Pediatric Cancer Patients
An additional dose of palonosetron can help prevent chemotherapy-induced nausea and vomiting (CINV) in children with cancer who are...
Oct 19, 2023
Supporting the Family Affected by a Pediatric Cancer Diagnosis: Siblings Matter, Too
A cancer diagnosis in a child impacts the entire family unit. Parents often have to shift their focus from after-school activities and ...
Oct 16, 2023
Blocking Immune Molecule Prolongs Survival in Models of the Most Aggressive Childhood Cancer
Researchers demonstrate that TIM-3 inhibition promotes immune memory in diffuse intrinsic stem glioma (DIPG). Read more:...
Oct 13, 2023
How do seizures affect childhood cancer survivors?
Scientists discovered suppressing seizures in adults who survived childhood cancer helps improve their brain function and quality of...
Oct 12, 2023
Most childhood cancer survivors face serious health problems as adults
In a sobering analysis, researchers warn that those who’ve had childhood cancer are highly likely to face physical and mental health...
Oct 11, 2023
FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML
The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...
Oct 10, 2023
It Takes a Lifetime to Survive Childhood Cancer
"Fending off early death is a victory. What the next four or five decades are like remains a challenge, for patients and families and...
Oct 6, 2023
Host genetics helps explain childhood cancer survivors’ mortality risk from second cancers
Using data from the Childhood Cancer Survivor Study (CCSS) and the St. Jude Lifetime Cohort Study (St. Jude Life), scientists at St....
Oct 5, 2023